U.S. Building Stock News

In late February 2026, Trupanion reported its full-year 2025 results, highlighting a return to profitability with net income of US$19.4 million and surpassing US$1.00 billion in annual subscription revenue driven by pricing aligned to rising veterinary costs and improved operating margins. The company also issued an optimistic 2026 outlook, projecting total revenue of about US$1.55–US$1.58 billion and targeting adjusted operating income growth of roughly 19%, while exploring lower-priced...

Bio-Rad Laboratories (BIO) has been drawing attention after a mixed stretch for the share price, with gains over the past year but declines over the past 3 months and year to date. See our latest analysis for Bio-Rad Laboratories. Recent trading has been choppy, with a 4.23% 7 day share price return following a weaker 30 day share price return of a 4.80% decline. A 12.23% decline over 90 days points to fading momentum despite a 9.02% 1 year total shareholder return. If this mixed performance...

Conagra Brands (NYSE:CAG) has added John Mulligan and Pietro Satriano to its board of directors. Mulligan and Satriano bring leadership experience from Target, McDonald's, US Foods, and Loblaw. The appointments signal a focus on retail operations, finance, and foodservice expertise at the board level. Conagra Brands, trading at $19.18, sits in a challenging spot after a 20.8% decline over the past year and a 33.5% decline over five years, even with a 10.9% gain year to date. For investors...

In February 2026, Centerspace reported fourth-quarter 2025 results showing sales of US$66.62 million and a net loss of US$18.38 million, alongside full-year sales of US$273.66 million and net income of US$17.59 million. The company paired this with 2026 guidance calling for a diluted net loss per share of US$0.49 to US$0.19, signaling a potential step back after returning to profitability in 2025. Next, we’ll examine how Centerspace’s return to profit in 2025 but projected loss in 2026...

In recent weeks, Iron Mountain Inc. has seen its short interest fall by 14.69%, with 3.6% of its freely traded shares now sold short, below the peer average of 5.54%. This pullback in bearish positioning suggests a meaningful shift in sentiment, as investors appear relatively more confident in Iron Mountain’s outlook than in many of its peers. With this backdrop of easing short interest, we’ll explore how changing investor sentiment could influence Iron Mountain’s evolving investment...

Helix Energy Solutions Group, Inc. recently reported fourth-quarter and full-year 2025 results showing lower sales and net income year-on-year, alongside a US$18,064,000 long-lived asset impairment and completion of a US$71.49 million share repurchase program that retired 9,094,398 shares since February 2023. As the company now evaluates acquisition opportunities and broader capital deployment, investors may weigh the tension between weaker recent performance and management’s appetite for...

Wondering whether Cigna Group is offering good value at around US$290.85 a share, or if the market is pricing it about right? This article walks through the key valuation angles you will want to consider. The stock has recently been steady to positive, with returns of 2.7% over the past 7 days, 6.1% over the past 30 days and 4.2% year to date, set against a 4.7% decline over the past year and longer term returns of 6.5% over 3 years and 34.8% over 5 years. These moves sit alongside ongoing...

In February 2026, Costamare Inc. reported that fourth-quarter 2025 revenue was US$211.97 million versus US$224.01 million a year earlier, with net income rising to US$80.46 million from US$28.86 million and full-year 2025 net income increasing to US$364.58 million on revenue of US$877.90 million. An interesting twist is that Costamare grew quarterly and full-year net income and basic earnings per share even as both quarterly and annual revenue edged lower year on year. We will now examine...

Irenic Capital Management has built an activist position in Ralliant (NYSE:RAL). The fund is urging cost cuts, a sharper focus on core businesses, and changes to capital allocation. Concerns include Ralliant’s recent cost levels and a recorded goodwill impairment. Irenic is also calling for faster share buybacks as part of its proposals. Ralliant, listed on the NYSE under ticker RAL, operates as a diversified business with exposure to several core segments that are tied to long term...

If you are wondering whether AutoNation's current share price offers real value or has already run too far, this article will walk through what the numbers actually suggest. The stock recently closed at US$193.04, with returns of 10.1% over 1 year, 38.9% over 3 years and 114.7% over 5 years. However, the most recent 7 day, 30 day and year to date returns show declines of 1.9%, 5.8% and 6.5% respectively. Recent headlines have focused on AutoNation's positioning as a large US auto retailer...

Nexstar Media Group, Inc. has already reported Q4 and full-year 2025 results, with Q4 sales of US$1,289 million versus US$1,488 million a year earlier and a Q4 net loss of US$166 million compared with prior net income of US$241 million, while full-year 2025 sales fell to US$4.95 billion and net income to US$109 million. Despite weaker year-on-year figures, the company surpassed analyst expectations for Q4 earnings and revenue, trimmed losses at The CW, and reaffirmed plans to close its...

Why Peloton Interactive Stock Is Drawing Attention Now Peloton Interactive (PTON) is back on many watchlists after recent trading left the share price around $3.90, with negative returns over the month and past 3 months sharpening investor focus on fundamentals. See our latest analysis for Peloton Interactive. The recent 30 day share price return of a 30.23% decline and year to date share price return of a 36.27% decline extend a much longer weak patch, with the 5 year total shareholder...

Pagaya Technologies (NasdaqCM:PGY) is shifting its business model toward an asset-light AI infrastructure approach. The company is pivoting away from riskier segments and focusing on partnering with major banks and fintechs. Its technology is being used in areas such as prime loans and buy now, pay later services with established financial institutions. Pagaya sits at the intersection of finance and data science, providing AI-driven infrastructure that helps banks and consumer finance...

Arcutis Biotherapeutics (ARQT) is back in focus after a cluster of company updates, including first patient dosing in a Phase 1a/1b study of ARQ-234 for atopic dermatitis and fresh financial guidance. See our latest analysis for Arcutis Biotherapeutics. Despite a 1-day share price return showing an 8.19% decline and a 90-day share price return showing a 15.87% decline to US$24.76, Arcutis Biotherapeutics still shows a 1-year total shareholder return of 92.99% and a 3-year total shareholder...

Key recent performance signals for Datavault AI Datavault AI (DVLT) has been drawing attention after a difficult past 3 months, with a return of about a 64% decline, while the share price most recently closed at US$0.68. Over the past month the stock shows a small positive return, in contrast with weaker year-to-date and 1-year total returns. This may prompt investors to reassess how they view Datavault AI at current levels. At the business level, Datavault AI reports revenue of US$6.17...

OneSpaWorld Holdings reported past fourth-quarter 2025 revenue of US$242.13 million, up from US$217.21 million a year earlier, while quarterly net income eased to US$12.06 million and long-lived asset impairment charges rose to US$2.97 million. Despite slightly lower profitability, the company reaffirmed its 2026 revenue outlook, maintained a quarterly US$0.05 dividend, and completed a US$37.5 million share repurchase, signaling continued commitment to returning cash to shareholders. Against...

If you are wondering whether Badger Meter is still worth a place on your watchlist after its recent swings, the key question is how its current share price lines up against underlying value. The stock closed at US$152.20 most recently, with returns of 3.8% over 30 days, a 2.6% decline over 7 days, and longer term moves of a 13.7% decline year to date, a 26.8% decline over 1 year, 29.9% over 3 years, and 57.3% over 5 years that may leave investors reassessing risk and return. Recent coverage...

Northern Trust agreed a new asset servicing mandate with CK Capital Partners, supporting its European fund servicing franchise. The firm is integrating Berenberg's AI based currency hedging models into its offering for asset servicing clients. Northern Trust expanded its collateralized loan obligation middle office services to meet changing institutional client needs in structured credit. Northern Trust, traded as NasdaqGS:NTRS, is moving to widen its role as a global asset servicer, while...

In February 2026, Allegion reported fourth quarter 2025 results showing higher year-over-year sales and net income, and issued full-year 2026 guidance calling for 5% to 7% reported revenue growth, 2% to 4% organic revenue growth, and reported EPS of US$8.00 to US$8.20 (US$8.70 to US$8.90 adjusted). The combination of continued revenue and earnings growth in 2025 alongside higher projected adjusted EPS for 2026 highlights how Allegion is leaning on its mix of security products and solutions...

Quarterly earnings beat sets fresh context for Atkore (ATKR) Atkore (ATKR) recently reported quarterly results that came in ahead of analyst expectations for both earnings per share and EBITDA, with revenue of US$655.5 million modestly above forecasts and roughly in line with last year. See our latest analysis for Atkore. The share price has been relatively muted around US$65.41, with a 1 day share price return of 1.08% and a 1 year total shareholder return of 13.38%. However, the 3 year...

If you are wondering whether Jazz Pharmaceuticals at around US$190 a share is priced attractively or already baking in a lot of expectations, you are in the right place. The stock has shown strong momentum recently, with returns of 9.9% over 7 days, 15.8% over 30 days, 10.0% year to date and 35.8% over the last year, on top of 33.4% and 18.0% over the past 3 and 5 years respectively. Recent news around Jazz Pharmaceuticals has focused on the company as a specialty pharma player and its...

Ryerson Holding Corporation recently reported fourth-quarter 2025 sales of US$1,104.8 million and a net loss of US$37.9 million, alongside full-year 2025 sales of US$4,571.3 million and a net loss of US$56.4 million, all compared with the prior year. Despite relatively steady annual sales, the company’s loss per share from continuing operations widened materially for both the quarter and full year, while it also completed a share repurchase program that retired 5,847,014 shares since its...

Cushman & Wakefield (NYSE:CWK) is expanding in Florida by adding brokerage and valuation teams to grow its presence in key regional markets. The company has launched an AI Impact Barometer to help clients assess how artificial intelligence affects real estate and the broader built environment. Cushman & Wakefield is a global commercial real estate services firm, and Florida is a major market for offices, industrial properties, housing and logistics. By bringing in new brokerage and...

Southern (SO) is back in focus after its fourth quarter earnings, where revenue topped analyst forecasts even as net income softened, and a larger five year capital plan caught investors’ attention. See our latest analysis for Southern. The fourth quarter update and the expanded US$81b five year capital plan have come alongside a 30 day share price return of 8.87% and a 90 day share price return of 9.20%. At the same time, the 1 year total shareholder return of 10.53% and 5 year total...